ライフサイエンスコーパス: incidence rate

1 ably lower age and had the highest yearly AD incidence rate.

2 timated with Cox regression and standardized incidence rates.

3 g a multivariate Poisson regression model of incidence rates.

4 ressure were negatively associated with ZIKV incidence rates.

5 ighest PHS percentiles showed the highest AD incidence rates.

6 % of the population, and calculated adjusted incidence rates.

7 (8.7%) experienced 37 inappropriate shocks (incidence rate 0.9 per 100 person-years).

8 cases during 190 164 person-years follow-up (incidence rate, 0.51/100 person-years).

9 the United Kingdom, death occurred in 1334 (incidence rate, 0.87/100 person-years), and HHF or death

10 (20.2%) had other ICD-related complications (incidence rate 1.4 per 100 person-years).

11 100 person-years), and HHF or death in 1983 (incidence rate, 1.38/100 person-years).

12 ed incidence compared with younger patients (incidence rate: 1.2 per 100 patient-years for patients y

13 Cumulative incidence rate/100,000 population (CIR) of new cases of

14 The incidence rates/1000 patient-years (95% confidence inter

15 ) were associated with dementia progression (incidence rate, 155 per 1000 person-years).

16 the intervention during 11204 patient-days (incidence rate, 16.1 vs 8.8 cultures per 100 patient-day

17 xperienced a total of 81 appropriate shocks (incidence rate 2.2 per 100 person-years).

18 ccurring during up to 12 years of follow-up (incidence rate 3.3 per 1,000 person-years).

19 subjects developed HF (9.0%; average annual incidence rate, 7.4 events per 1000 person-years).

20 oped AF during the 20-year follow-up period (incidence rate, 8.2; 95% CI, 6.8-9.6 per 1000 person-yea

21 a significant reduction in colorectal cancer incidence rate (adjusted hazard ratio 0.57, 95% CI 0.40-

22 y acute illnesses among surfers, with higher incidence rates after rainstorms.

23 The adjusted incidence rate (AIR) of S Typhi per 100 000 person-years

24 icantly different periods in terms of annual incidence rates (AIR) were identified, overlapping respe

25 0 children, the average annual RSV infection incidence rates among children aged <3, 3-6, and 7-13 ye

26 Given the unequal incidence rates among men and women (male:female inciden

27 2030, Asians are forecast to have the lowest incidence rates among men, and Hispanics are forecast to

28 Annualized incidence rates among MSM and non-MSM were compared thro

29 Retrospective, longitudinal incidence rate analysis of the National Inpatient Sample

30 We aimed to determine the incidence rate and causes of anaphylaxis during a 10-yea

31 Our objective was to evaluate the incidence rate and cumulative probability of having a po

32 Malignancies occur with a higher incidence rate and manifest earlier in life in patients

33 increased 3% annually, with increases in the incidence rate and thyroid cancer mortality rate for adv

34 We present incidence rates and adjusted hazard ratios (aHRs).

35 Incidence rates and incidence rate ratios (IRRs) for all

36 were performed to assess differences in CDI incidence rates and mortality after CDI between individu

37 strong correlation was observed between IIH incidence rates and obesity rates in Minnesota (R(2) = 0

38 nd on the correlation between lung carcinoma incidence rates and our log-based statistics.

39 By combining population-based incidence rates and the genotype-derived PHS for each in

40 aribbean, a finding corroborated by the high incidence rates and traffic volumes from the region into

41 h antithrombotic drug use, subdural hematoma incidence rate, and annual prevalence of treatment with

42 Annual case count, incidence rate, and trend over time were calculated.

43 Incidence rates are age and sex standardized for the Ita

44 cidence rates (WSRs), using the age-specific incidence rates (ASR) for individual age groups (0-4 yea

45 Incidence rates based on physician adjudication were 4.7

46 There was no significant difference in GI incidence rate between periods of dabigatran and warfari

47 We find that mortality incidence rates decrease with increasing income.

48 HO-CDI incidence rate decreased from an average of 13.0 cases t

49 tive tract among high-risk patients, and the incidence rate decreased to baseline.

50 The yearly HCC incidence rate did not differ within and after the first

51 Adjusted incidence rate differences between person-quarters (expo

52 p < 0.002) positive correlation with cancer incidence rates, especially when the five cancers with m

53 The incidence rate for ESRD among participants with APOL1 hi

54 The incidence rate for ESRD was 8.5 per 1000 person-years fo

55 Compared with NOAC use alone, the adjusted incidence rate for major bleeding was significantly lowe

56 , whereas the expected national age-adjusted incidence rate for this same group was 7.04 per 100,000

57 Age- and sex-standardized incidence rates for CDI and mrCDI.

58 rall CVD were additional designated outcomes.Incidence rates for CHD and total CVD did not differ bet

59 We map measles incidence and incidence rates for each of the 344 cities in mainland C

60 We calculated incidence rates for HD, HCC, and all-cause mortality at

61 We estimated incidence rates for malignancy and HLH as events/1000 pa

62 ities did not explain the decreased dementia incidence rates for more recent birth cohorts.

63 8 patients followed for OHT, the mean annual incidence rates for OHT >/=21 mmHg and OHT >/=30 mmHg ar

64 ia Cancer Registry to calculate age-adjusted incidence rates for over 58,000 newly diagnosed melanoma

65 The incidence rates for posttransplant skin cancer overall a

66 The incidence rates for posttransplant skin cancer was 1437

67 After the calculation of annual incidence rates for the 2002-2012 period, we analyzed tr

68 For high-titer inhibitors, the incidence rate had an almost threefold increase (HR, 2.7

69 Trends in dementia incidence rates have important implications for planning

70 Incidence rates, hazard ratios (HRs), and 95% confidence

71 patients' health care contacts and estimated incidence rates, health service burden, pharmacologic tr

72 ssociated with a decreased 3-month rejection incidence rate in patients with complement-activating DS

73 The IMCI pneumonia incidence rate in the intervention group was 15.76 (95%

74 tically significantly correlated with cancer incidence rates in 5 of 8 commonly diagnosed cancers in

75 The mortality rates paralleled the incidence rates in most countries.

76 When deltamethrin was used for IRS, incidence rates in the LLIN + IRS arm and the LLIN-only

77 2003 to 2015 and compared with age-adjusted incidence rates in the SEER database.

78 The overall subdural hematoma incidence rate increased from 10.9 per 100000 person-yea

79 sed protection against RVGE, decomposing the incidence rate into the rate of rotavirus infection and

80 Yearly Pf clinical incidence rate (IR = 0.28) was higher than for Pv (IR =

81 Average annual incidence rate (IR) was 11.4 cases/100000 persons, with

82 a cases occurred: 220 in unexposed patients (incidence rate [IR] per 1000 person-years, 0.26; 95% CI,

83 We calculated crude incidence rates (IRs) and developed Cox proportional haz

84 Poisson regression was used to calculate incidence rates (IRs) and risk differences of adjudicate

85 The projected incidence rate is 290 per 100 000 population (95% CI 237

86 Descriptive statistics, incidence rates, Kaplan-Meier survival curves, and the R

87 Incidence rates not only continued to rise over the 10-y

88 The incidence rate of </=20/200 was 0.66/eye-year (EY), (95%

89 nly 1 patient developed PCP, resulting in an incidence rate of 0.1%.

90 d 27 progressed to dementia (24.1%), with an incidence rate of 121 per 1000 person-years.

91 with ICC in Thailand is significant with the incidence rate of 14.6 per 100,000 population, per year

92 od (on average, 6865 patients/year, with the incidence rate of 14.6 per 100,000 population, per year.

93 pulation (95% CI, 2.85-3.23) and an adjusted incidence rate of 2.78 per 100000 population (95% CI, 2.

94 ected) diabetes at baseline, with an overall incidence rate of 2.8 per 1,000 person-years.

95 95 and 2014, corresponding to a crude annual incidence rate of 3.03 per 100000 population (95% CI, 2.

96 73 social groups, across 12 of 14 years (an incidence rate of 3.78 cases/100 study years).

97 genitalium infections among 50 women, for an incidence rate of 34.6 cases per 100 person-years.

98 BD at 60 years or older, corresponding to an incidence rate of 35/100,000 person-years (10/100,000 pe

99 validated SJS/TEN patients, we calculated an incidence rate of 5.76 SJS/TEN cases per million person-

100 The cumulative incidence rate of a second primary malignancy before dis

101 nce rate ratios (IRRs) were estimated as the incidence rate of alcoholic liver cirrhosis in these pat

102 pha power rose because of an increase in the incidence rate of alpha episodes, whereas the amplitude

103 The estimated incidence rate of anaphylaxis was 26 cases per 100 000 p

104 The overall incidence rate of anaphylaxis was 42 per 100,000 person-

105 ary objective) was measured by comparing the incidence rate of ARD among all children age-eligible fo

106 The incidence rate of ARD was 4.10 cases per 100 person-year

107 The incidence rate of back pain was 18.6 per 100 person-year

108 The incidence rate of BE recurrence was 10.8 per 100 person-

109 The incidence rate of childhood ALL was negatively associate

110 is observational study demonstrated a higher incidence rate of CV/CBV events in the omalizumab versus

111 The incidence rate of dysplasia recurrence was 5.2 per 100 p

112 th the prevalence of normal test results and incidence rate of events in these patients were signific

113 Cumulative incidence rate of first alcohol relapse was 25.2%, 33.7%

114 n, there was a 9.8% increase per year in the incidence rate of food-related anaphylaxis.

115 er to pool results and determine the overall incidence rate of gastric cancer for patients with these

116 adjustment for time-variant confounders, the incidence rate of gastrointestinal bleeding was similar

117 Overall there is a wide variation in annual incidence rate of GC from premalignant lesions.

118 The incidence rate of GC in patients with GA ranged from 0.5

119 dabigatran was not associated with increased incidence rate of GI bleeding compared with non-exposed

120 The incidence rate of M. abscessus increased from 0.7 cases

121 The incidence rate of MA in the 3 groups was 40%, 0%, and 8.

122 The incidence rate of NLP was 0.04 cases per eye-year of fol

123 Hunan Province in southern China has a high incidence rate of NPCs.

124 At the end of follow-up, the incidence rate of P. vivax was 2.2 episodes/person-year

125 ALP and no evidence of cirrhosis, the 5-year incidence rate of PBC was 16%.

126 The overall incidence rate of PEx was 521.9 per 10000 person-months.

127 The 8-year cumulative incidence rate of secondary malignancies was 1.3 +/- 0.5

128 The age-standardized incidence rate of squamous cell carcinoma (SCC) was high

129 Incidence rate of the disease is estimated at 0.4-2 case

130 In 2013, the incidence rate of thyroid cancer in the United States wa

131 and 310 treated patients developed NHL, with incidence rates of 219 and 168 cases per 100 000 person-

132 n the no-alendronate group, corresponding to incidence rates of 9.5 (95% CI, 6.5-13.9) and 27.2 (95%

133 ure to seawater during dry weather increased incidence rates of all outcomes (e.g., for earache or in

134 High and increasing incidence rates of BCC in the very elderly were found ra

135 ients) were found that included age-specific incidence rates of BCC in the very elderly.

136 Incidence rates of cerebral palsy and hazard ratios (HRs

137 Incidence rates of colonoscopy, flexible sigmoidoscopy,

138 The incidence rates of corticosteroid-related AEs among plac

139 from VISUAL-1 and VISUAL-2 suggests that the incidence rates of corticosteroid-related AEs increase s

140 ssociation between corticosteroid dosage and incidence rates of corticosteroid-related AEs.

141 eports have suggested declining age-specific incidence rates of dementia in high-income countries ove

142 The incidence rates of ESRD for nonchronically HCV-infected

143 We calculated the annual incidence rates of HCC by SVR.

144 Annual incidence rates of heart failure and 1-year standardized

145 y group had higher remission rates and lower incidence rates of hypertension and dyslipidemia than di

146 Population-based incidence rates of HZ-related ED visits, charge for ED s

147 The incidence rates of IIH were compared against the inciden

148 Mean annual incidence rates of MA-NGE were 4.9/1000 person-years and

149 We compared unadjusted incidence rates of malignancy and HLH in pediatric patie

150 rban coastal seawater exposure increases the incidence rates of many acute illnesses among surfers, w

151 acebo or observation, whereas the cumulative incidence rates of progression, death, or death as a res

152 olute changes during the study period in the incidence rates of sentinel outcomes per 10,000 person-y

153 h a 1-time screening, a 4.0% decrease in the incidence rates of stage III and IV melanoma was predict

154 The cumulative incidence rates of sudden death were assessed at differe

155 The reported incidence rates of thrombosis, any bleeding, and major b

156 Overall unadjusted estimated incidence rates of type 1 diabetes increased by 1.4% ann

157 Overall unadjusted incidence rates of type 2 diabetes increased by 7.1% ann

158 crosis (ARN), presenting characteristics and incidence rates of vision loss and ocular complications

159 Main outcome measures included incidence rates of vision loss and retinal detachment (R

160 To describe the incidence rates of visual loss and ocular complications

161 Annual standardized incidence rates of WL were analyzed using Poisson regres

162 This could indicate true stability in incidence rates, or a balance between increased detectio

163 relevant in explaining the variation of ALS incidence rates over time in the overall population (cha

164 Using data from 14 countries, we modelled incidence rates over time using linear mixed-effects mod

165 d lower rates of epinephrine administration (incidence rate per 10,000 students 0.2 and 0.6, respecti

166 rt failure between 1995 and 2012; the annual incidence rates per 10 000 person-years declined among o

167 Age-standardized incidence rates per 100,000 person-years were calculated

168 dent hypertension than other PRA phenotypes (incidence rates per 1000 person-years of follow-up: supp

169 NOACs had a significant increase in adjusted incidence rates per 1000 person-years of major bleeding

170 Incidence rates per 1000 person-years were calculated, a

171 KS incidence rates per 100000 person-years were 52 in the A

172 Incidence rates per million person-years for the 0-14 ye

173 To determine the incidence rate, principal causes, and clinical course of

174 udies (four over 25,000 person years) had an incidence rate range of 1.0-2.5 per 1000 person years, h

175 hich was higher than the general population [incidence rate ratio (IRR) 1.47, 95% confidence interval

176 (2.5 per 100 person-years [95% CI 0.4-9.4]; incidence rate ratio (IRR) 3.7 (95% CI 0.4-15.8; p=0.23)

177 erms representing 1,5-AG levels <6.0 mug/mL (incidence rate ratio (IRR) = 0.79, 95% confidence interv

178 the IRS providing no additional protection [incidence rate ratio (IRR) = 1.0 (95% confidence interva

179 es (e.g., for earache or infection, adjusted incidence rate ratio (IRR) = 1.86, 95% confidence interv

180 d-years, with an intervention versus control incidence rate ratio (IRR) of 1.01 (95% CI 0.91-1.13; p=

181 vs. 1.7; N = 48 cases), corresponding to an incidence rate ratio (IRR) of 2.9 (95% confidence interv

182 efore methylphenidate was initiated, with an incidence rate ratio (IRR) of 6.55 (95% CI, 3.37-12.72).

183 h the relationship problems subscale at 3 y [incidence rate ratio (IRR): 1.11; 95% confidence interva

184 us BB reduced overall rebleeding in Child A (incidence rate ratio 0.40; 95% confidence interval, 0.18

185 ificant reduction in mortality in Child B/C (incidence rate ratio 0.46; 95% confidence interval, 0.25

186 o approximately 3% in February, 2013; annual incidence rate ratio 0.52, 95% CI 0.48-0.56 vs fluoroqui

187 olicy introduction compared with beforehand (incidence rate ratio 0.61, 95% CI 0.53-0.70; p<0.0001).

188 rts, incidence of herpes zoster fell by 35% (incidence rate ratio 0.65 [95% 0.60-0.72]) and of posthe

189 catch-up cohorts was 33% for herpes zoster (incidence rate ratio 0.67 [0.61-0.74]) and 38% for posth

190 eart failure than were affluent individuals (incidence rate ratio 1.61, 95% CI 1.58-1.64), and did so

191 13%) of 680 had tested in the delayed group (incidence rate ratio 4.8, 95% CI 3.7-6.4).

192 higher risk of relapses (97.5th percentile: incidence rate ratio = 1.94, 95% confidence interval [CI

193 3.6), longer intensive care length of stay (incidence rate ratio = 2.0, 99% CI: 1.9, 2.2), stillbirt

194 ]) and subsequent prolapse surgery (adjusted incidence rate ratio [aIRR] 0.30 [0.24-0.39]), and a sim

195 icosteroids among all participants (adjusted incidence rate ratio [aIRR] 0.74, 95% CI 0.56-0.97; p=0.

196 ence was lower in liver recipients (adjusted incidence rate ratio [aIRR] = 0.52), similar in heart an

197 for all groups (MMN-0 versus MMN-6: adjusted incidence rate ratio [IRR] 1.03, 95% CI: 0.92, 1.16; MMN

198 risk of symptomatic malaria during infancy (incidence rate ratio [IRR] = 0.68 [95% CI 0.51, 0.91], p

199 bigatran risk period and non-exposed period (incidence rate ratio [IRR] = 1.01, 95% confidence interv

200 significantly more frequent among biologics (incidence rate ratio [IRR] = 1.93; 95% CI, 1.06-3.52; P

201 In the multivariable model, younger age (incidence rate ratio [IRR], 1.05; 95% CI, 1.03-1.06), in

202 ertificate had greater eye health knowledge (incidence rate ratio [IRR], 1.08; 95% CI, 1.01-1.15 and

203 ade 2 adverse event rates between daily gel (incidence rate ratio [IRR], 1.09; P = .59) or RAI gel (I

204 gher rates of unauthorized absence (adjusted incidence rate ratio [IRR], 1.16; 95% CI, 1.14-1.19) and

205 ficantly associated with black non-Hispanic (incidence rate ratio [IRR], 1.29; 95% CI, 1.17 to 1.42)

206 ence, 43.8; 95% CI, 43.0-44.6; P < .001, and incidence rate ratio [IRR], 1.44; 95% CI, 1.42-1.46).

207 pants had an increased risk of liver events (incidence rate ratio [IRR], 6.29 [95% confidence interva

208 risk of MI was significantly higher for ASA (incidence rate ratio [IRR]: 1.54; 95% confidence interva

209 oratory-confirmed infections between groups (incidence rate ratio [RR], 0.97; 95% CI, 0.80-1.16).

210 In multiple Poisson regression analysis, the incidence rate ratio in the employed syncope population

211 ly in 2012-13 compared with 2011-12, with an incidence rate ratio of 1.8 (1.2-2.8).

212 ) differed significantly (P < 0.001) with an incidence rate ratio of 1.86 (95% confidence interval, C

213 per 100 person-years in the CTX arm, with an incidence rate ratio of 4.3 (95% confidence interval, 2.

214 ly in 2015-16 compared with 2014-15, with an incidence rate ratio of 5.2 (95% CI 2.0-13.5) and 11% ca

215 .03, 0.16]); the hydroxyurea/placebo malaria incidence rate ratio was 0.7 ([0.2, 2.7]; P = .61).

216 2010 to 0.39/100000 in 2013-2014 (14 deaths; incidence rate ratio, 0.31 [95% confidence interval, .16

217 the placebo group (7.2 [95% CI, 4.7-11.0]) (incidence rate ratio, 0.43 [95% CI, .19-.93]) for a vacc

218 ); declines were greater among men (adjusted incidence rate ratio, 0.46; 95% CI, 0.29 to 0.73) than a

219 ention in the blood culture collection rate (incidence rate ratio, 0.54; 95% CI, 0.50-0.59).

220 to 0.66 cases per 100 person-years (adjusted incidence rate ratio, 0.58; 95% confidence interval [CI]

221 CI, 0.29 to 0.73) than among women (adjusted incidence rate ratio, 0.68; 95% CI, 0.50 to 0.94).

222 attempts than participants in the TAU phase (incidence rate ratio, 0.72; 95% CI, 0.52-1.00; P = .05)

223 ciated with shorter adjusted length of stay (incidence rate ratio, 0.86; 95% CI, 0.75-0.98) but not c

224 ospital length of stay was also significant (incidence rate ratio, 0.91; 95% CI, 0.89 to 0.92), decre

225 rences between the TAU and screening phases (incidence rate ratio, 1.00; 95% CI, 0.71-1.41; P = .99).

226 ith 128 (61.6%) ACOs reporting improvements (incidence rate ratio, 1.04; 95% confidence interval: 1.0

227 rthritis) and increased all-cause mortality (incidence rate ratio, 1.35 [95% CI, 1.15-1.59]).

228 res than the in-person follow-up care group (incidence rate ratio, 1.39; 95% CI, 1.09-1.77; P = .008)

229 ermination of employment were age <40 years (incidence rate ratio, 1.48; 95% CI, 1.37-1.59), cardiova

230 n the screening versus prescreening periods (incidence rate ratio, 1.49 [95% CI, 1.43 to 1.54]).

231 risks for developing mental disorders (men: incidence rate ratio, 1.7; 95% CI, 1.5-1.9; women: incid

232 nce rate ratio, 1.8; 95% CI, 1.6-2.0; women: incidence rate ratio, 1.7; 95% CI, 1.6-1.8) than the gen

233 l disorders within 5 years of the loss (men: incidence rate ratio, 1.8; 95% CI, 1.6-2.0; women: incid

234 nce rate ratio, 1.7; 95% CI, 1.5-1.9; women: incidence rate ratio, 2.0; 95% CI, 1.9-2.2), suicidal be

235 -1.00]; p = 0.01), longer delirium duration (incidence rate ratio, 2.47 [1.36-4.49]; p = 0.005), and

236 n those without AIDS (ie, HIV only; adjusted incidence rate ratio, 3.82; 95% CI, 3.27 to 4.46).

237 ays after the operation (mean, 0.65 vs 0.15; incidence rate ratio, 4.13; 95% CI, 1.55-10.99; P = .005

238 se 1 of the outbreak (August 2013-May 2014) (incidence rate ratio, 4.6 [95% confidence interval, 2.3-

239 as well as with lower socioeconomic status (incidence rate ratio: 1.3; 95% CI=1.2-1.4) and in more u

240 Rates increased for ethnic minority groups (incidence rate ratio: 1.4; 95% CI=1.1-1.6), as well as w

241 tio: 1.3; 95% CI=1.2-1.4) and in more urban (incidence rate ratio: 1.4;95%CI=1.0-1.8) and deprived (i

242 rate ratio: 1.4;95%CI=1.0-1.8) and deprived (incidence rate ratio: 2.1; 95% CI=1.3-3.3) neighborhoods

243 occurring in cancer patients and comparative incidence rate ratios (IRR) to the general population fr

244 We calculated incidence rate ratios (IRRs) and 95% CIs for each year a

245 ations at the 22q11.2 locus and estimate the incidence rate ratios (IRRs) and absolute risk for psych

246 priate later comparison periods to calculate incidence rate ratios (IRRs) by serotype and age using a

247 Adjusted incidence rate ratios (IRRs) for all antihyperlipidemics

248 Incidence rates and incidence rate ratios (IRRs) for all-cause mortality and

249 We calculated incidence rate ratios (IRRs) for stillbirth and infant m

250 We estimated incidence rate ratios (IRRs) of asthma among children bo

251 The incidence rate ratios (IRRs) of suspected and confirmed

252 Incidence rate ratios (IRRs) were calculated by Poisson

253 Incidence rate ratios (IRRs) were estimated as the incid

254 Incidence rate ratios (IRRs) were estimated for patients

255 a Bayesian network meta-analysis to produce incidence rate ratios (IRRs) with 95% credible intervals

256 Sex-specific incidence rate ratios (IRRs; relative risks) and cumulat

257 Incidence rate ratios (RRs) of ICH.

258 Incidence rate ratios among VISUAL-2 patients were simil

259 Incidence rate ratios and 95% confidence intervals assoc

260 ts meta-analysis was used to generate pooled incidence rate ratios and relative risks, or risk differ

261 Sex- and age-adjusted incidence rate ratios for 2012 versus 1996 were 0.69 (95

262 s compared with the lowest SEP, the adjusted incidence rate ratios for children with the highest SEP

263 Incidence rate ratios for hospitalization for AHT increa

264 The incidence rate ratios for the intensive compared with th

265 related carcinomas and premalignancies, with incidence rate ratios of 3.85 (95% CI, 2.32 to 6.37) for

266 te analyses, calculated Poisson proportional incidence rate ratios to estimate the effect of rapid pr

267 Incidence rate ratios were calculated using Poisson regr

268 Incidence rate ratios were estimated following multivari

269 Incidence rate ratios were estimated for carcinomas and

270 Adjusted relative risks, incidence rate ratios, and 99% confidence intervals were

271 a conditional Poisson regression to estimate incidence rate ratios.

272 Secondary objectives include determining the incidence rate, relative risk (RR), and survival probabi

273 The incidence rate resulted in 30.91 PI-CC per 1000 person-y

274 Unadjusted incidence rates showed no increased risk of malignancy (

275 There was no significant overall change in incidence rates since the start of a national dementia p

276 However, incidence rates started to rise again since 2008.

277 an 0.7 IU/ml had 10-fold higher tuberculosis incidence rates than those who maintained values less th

278 imated by applying general population cancer-incidence rates to person-time in the HIV population bas

279 The yearly HCC incidence rate was 1.22% within and 0.73% after the firs

280 The overall age- and sex-adjusted incidence rate was 42 (95% CI, 38.7-45.3) per 100,000 pe

281 The age- and sex-adjusted annual incidence rate was 5.73 per 100 000 per year (95% confid

282 The annual growth in dementia incidence rate was estimated to be 2.1% (95% CI 0.5% to

283 The incidence rate was significantly decreased by 14% during

284 imated to be 2.1% (95% CI 0.5% to 3.8%), and incidence rates were 1.08 (95% CI 1.04 to 1.13) times hi

285 8 registry grouping (2000-2012), the highest incidence rates were 1.49 per 100000 in the lung, 3.56 p

286 The age-standardized incidence rates were 34.8, 37.3, 34.9, and 35.6 /1000 pe

287 Incidence rates were 394/1,000 patient-years for communi

288 age group, sex, and year of anaphylaxis with incidence rates were assessed by fitting Poisson regress

289 Incidence rates were calculated and adjusted hazard rati

290 Age-specific dementia incidence rates were calculated for all persons aged 60

291 Cumulative incidence rates were calculated using competing risk sur

292 Overall and site-specific cancer incidence rates were evaluated in subjects with PIDD (n

293 23.4 years; interquartile range: 19.5-29.1); incidence rates were highest for men and women before 20

294 Incidence rates were highest in children aged <5 years:

295 The greatest GC incidence rates were in Asian countries, for patients wi

296 el-predicted changes in vaccine-serotype IPD incidence rates were similar to the observed changes in

297 Incidence rates were widely variable: 1% to 41% for outc

298 icular tachycardia, there was an increase in incidence rate with ages (P<0.001) but not between sexes

299 of 283 patients had a serious infection; the incidence rates with 95% confidence intervals (CI) per 1

300 ndard population to provide age-standardised incidence rates (WSRs), using the age-specific incidence